Research Associate II, Research (Myeloid Biology) at BlueRock Therapeutics

New York, New York, United States

BlueRock Therapeutics Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Cell Therapy, PharmaceuticalsIndustries

Requirements

  • Degree in Biological Sciences (Cell Biology, Stem Cell Biology, Molecular Biology, etc.) or related discipline (B.S. with 0-5 years or M.S. with 0-2 years of experience)
  • Experience with microglia/macrophage cells highly desired but not required
  • Prior hands-on experience with cell-based assays and characterization

Responsibilities

  • Be responsible for data generation, collection, interpretation, and communication of results under supervision
  • Mammalian cell culture; maintenance of cell lines and primary cells under stringent sterility conditions
  • Execute plate reader assays (e.g., ELISA, Luminescence, biochemical assays)
  • Perform DNA/RNA-based, flow cytometric, immunofluorescence, and other analytical assays as required
  • Perform cell-based assays to evaluate cell function, behavior, phenotype
  • Analyze and document experimental data in electronic laboratory notebooks in a timely and accurate manner in accordance with the company quality management system
  • Present scientific data to colleagues in group meetings, prepare and present internal and external presentations (presentations, posters, publications) as required
  • Collaborate with other team members as needed to advance programs
  • Perform additional duties to support the safe and efficient operation of the laboratory, and other duties as assigned
  • Collaborate with various functional groups including research teams, discovery analytics, in vivo sciences, and gene editing to advance projects, including the coordination of sample testing, data analysis, and reporting

Skills

cell therapy
pluripotent stem cells
cell differentiation
molecular assays
cell-based assays
Myeloid Biology
cellular therapies
gene therapy

BlueRock Therapeutics

Develops advanced cellular therapies for diseases

About BlueRock Therapeutics

BlueRock Therapeutics develops advanced cellular therapies using a unique cell gene platform that directs cellular differentiation and genetically engineers cells. This technology allows them to create new types of medicines aimed at treating complex diseases in areas such as neurology, cardiology, and immunology. Their products work by transforming cells to target specific medical conditions, including neurodegenerative diseases, heart failure, and immune disorders. Unlike many competitors, BlueRock focuses on a specialized approach within the rapidly growing field of regenerative medicine, emphasizing strategic partnerships and research and development to advance their therapies. The company's goal is to address challenging medical conditions through innovative cellular treatments and to generate revenue through collaborations, licensing agreements, and eventual commercialization of their therapies.

Cambridge, MassachusettsHeadquarters
2016Year Founded
$218.9MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Hybrid Work Options

Risks

Competition from established firms like Johnson & Johnson may overshadow BlueRock's innovations.
Reliance on strategic partnerships poses risks if partners shift focus or resources.
Regulatory hurdles could delay product launches, impacting revenue and market position.

Differentiation

BlueRock uses iPSC technology to create novel cellular therapies for complex diseases.
Their strategic partnerships enhance R&D capabilities and expand therapeutic applications.
Focus on neurology, cardiology, and immunology addresses challenging medical conditions.

Upsides

FDA RMAT designation for bemdaneprocel accelerates market entry for Parkinson's therapy.
Successful Phase I trial of bemdaneprocel boosts investor confidence and funding potential.
Collaboration with bit.bio enhances discovery and development of new cell therapies.

Land your dream remote job 3x faster with AI